AAAAAA

   
Results: 1-10 |
Results: 10
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer
Authors: Umbricht, CB Evron, E Gabrielson, E Ferguson, A Marks, J Sukumar, S
Citation: Cb. Umbricht et al., Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer, ONCOGENE, 20(26), 2001, pp. 3348-3353
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
Authors: Evron, E Dooley, WC Umbricht, CB Rosenthal, D Sacchi, N Gabrielson, E Soito, AB Hung, DT Ljung, BM Davidson, NE Sukumar, S
Citation: E. Evron et al., Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR, LANCET, 357(9265), 2001, pp. 1335-1336
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation
Authors: Evron, E Umbricht, CB Korz, D Raman, V Loeb, DM Niranjan, B Buluwela, L Weitzman, SA Marks, J Sukumar, S
Citation: E. Evron et al., Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation, CANCER RES, 61(6), 2001, pp. 2782-2787
High frequency of hypermethylation at the 14-3-3 sigma locus leads to genesilencing in breast cancer
Authors: Ferguson, AT Evron, E Umbricht, CB Pandita, TK Chan, TA Hermeking, H Marks, JR Lambers, AR Futreal, PA Stampfer, MR Sukumar, S
Citation: At. Ferguson et al., High frequency of hypermethylation at the 14-3-3 sigma locus leads to genesilencing in breast cancer, P NAS US, 97(11), 2000, pp. 6049-6054
Applications of telomerase research in the fight against cancer
Authors: McKenzie, KE Umbricht, CB Sukumar, S
Citation: Ke. Mckenzie et al., Applications of telomerase research in the fight against cancer, MOL MED TOD, 5(3), 1999, pp. 114-122
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms
Authors: Saji, M Xydas, S Westra, WH Liang, CK Clark, DP Udelsman, R Umbricht, CB Sukumar, S Zeiger, MA
Citation: M. Saji et al., Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms, CLIN CANC R, 5(6), 1999, pp. 1483-1489
Telomerase activity in ductal carcinoma in situ and invasive breast cancer
Authors: Umbricht, CB Sherman, ME Dome, J Carey, LA Marks, J Kim, N Sukumar, S
Citation: Cb. Umbricht et al., Telomerase activity in ductal carcinoma in situ and invasive breast cancer, ONCOGENE, 18(22), 1999, pp. 3407-3414
Telomerase activity as a measure for monitoring radiocurability of tumor cells
Authors: Sawant, SG Gregoire, V Dhar, S Umbricht, CB Cvilic, S Sukumar, S Pandita, TK
Citation: Sg. Sawant et al., Telomerase activity as a measure for monitoring radiocurability of tumor cells, FASEB J, 13(9), 1999, pp. 1047-1054
Telomerase activity and prognosis in primary breast cancers
Authors: Carey, LA Kim, NW Goodman, S Marks, J Henderson, G Umbricht, CB Dome, JS Dooley, W Amshey, SR Sukumar, S
Citation: La. Carey et al., Telomerase activity and prognosis in primary breast cancers, J CL ONCOL, 17(10), 1999, pp. 3075-3081
High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor
Authors: Dome, JS Chung, S Bergemann, T Umbricht, CB Saji, M Carey, LA Grundy, PE Perlman, EJ Breslow, NE Sukumar, S
Citation: Js. Dome et al., High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor, CANCER RES, 59(17), 1999, pp. 4301-4307
Risultati: 1-10 |